コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ar whether there is also an association with geriatric depression.
2 ortions of the posterior cingulate cortex in geriatric depression.
3 ortico-striato-limbic networks implicated in geriatric depression.
4 uld provide useful diagnostic information in geriatric depression.
5 s in the mechanisms underlying the course of geriatric depression.
6 H volume is associated with poor outcomes in geriatric depression.
7 imaging (MRI) scans and are associated with geriatric depression.
8 igms that may clarify the pathophysiology of geriatric depression.
9 e associated with a low rate of remission of geriatric depression.
10 e associated with a low rate of remission of geriatric depression.
11 constitute contributing neural substrates of geriatric depression.
12 bout the cognitive response to treatment for geriatric depression.
13 ion to influence the etiology and therapy of geriatric depression.
14 commonly observed in the elderly, including geriatric depression.
15 licating the basal ganglia in depression and geriatric depression.
16 s of daily living can improve the outcome of geriatric depression.
17 mbined with venlafaxine for the treatment of geriatric depression.
18 age of an ecological momentary assessment of geriatric depression.
19 egarding late-life mental disorders, such as geriatric depression.
20 sed frontotemporal function in patients with geriatric depression, a debilitating and increasingly pr
21 to determine if P300 latency is prolonged in geriatric depression and if longer P300 latency and defi
22 ociated with poor antidepressant response of geriatric depression and may represent a neuroanatomical
23 validate cognitive performance decrements in geriatric depression and suggest possible neuroanatomic
24 erize the neuropsychological presentation of geriatric depression and to determine whether depression
25 re associated with relapse and recurrence of geriatric depression and with fluctuations of depressive
32 ed double-blind placebo-controlled trial for geriatric depression in 143 older outpatients diagnosed
33 depression in older adults demonstrate that geriatric depression is a serious medical condition that
37 vidence of structural brain abnormalities in geriatric depression, particularly in patients with a lo
38 mination score of 24 to 27 received 1 point; Geriatric Depression Scale >4, prior stroke/transient is
40 come was treatment response according to the Geriatric Depression Scale (GDS) and Beck Depression Inv
41 ents to assess depressive symptoms using the Geriatric Depression Scale (GDS) and physical function u
47 e derived from relevant items of the 15-item Geriatric Depression Scale (GDS-15) and part I of the MD
48 curacy and not to assess prevalence, but the Geriatric Depression Scale (GDS-15) is often used to est
50 d Parkinson's Disease Rating Scale part III, Geriatric Depression Scale (GDS-15), RBD medication use,
51 tom scores after 12 months measured with the Geriatric Depression Scale (GDS-15), with higher scores
52 g (IADL), Mini Nutritional Assessment (MNA), Geriatric Depression Scale (GDS15), and comorbidities in
53 (MNA), Mini-Mental State Examination (MMSE), Geriatric Depression Scale (GDS15), and Timed Get Up and
57 ssive symptoms were measured by means of the Geriatric Depression Scale and categorized as no depress
58 ) genotype had been determined completed the Geriatric Depression Scale and received an MRI scan.
59 hiatric Inventory-Questionnaire, the 15-item Geriatric Depression Scale and the Clinical Dementia Rat
60 were defined by a score >/=6 on the 15-item Geriatric Depression Scale and/or use of antidepressant
61 nical depressive symptoms (defined using the Geriatric Depression Scale at baseline) from the Age-Wel
62 ; nfvPPA-CBD, 0 [0-4]; P = .02), depression (Geriatric Depression Scale median [IQR] score: nfvPPA-PS
63 r Disease Assessment Scales (ADASs), and the Geriatric Depression Scale over time were similar in AD
64 nation executive function and memory scores, Geriatric Depression Scale score and three or more cardi
65 e of self-rated depression more severe (mean Geriatric Depression Scale score of 2.8 versus 1.4, P =
66 ination score of less than 20, and shortened Geriatric Depression Scale score of 7 or higher, creatin
67 ere qualitatively similar when change in the Geriatric Depression Scale score over time was used as t
73 e and severity of depressive symptoms on the Geriatric Depression Scale using generalized linear regr
76 omery-Asberg Depression Rating Scale and the Geriatric Depression Scale were used to assess severity
78 0001), less frequent symptoms of depression (Geriatric Depression Scale, adjusted P=0.01), and lower
79 ep Behavior Disorder Single-Question Screen, Geriatric Depression Scale, and Montreal Cognitive Asses
80 ur Disorder Screening Questionnaire [RBDSQ], Geriatric Depression Scale, and Movement Disorder Societ
81 & Go, Mini-Mental State Examination, 15-item Geriatric Depression Scale, marital status, and living s
82 lth-related quality of life (EuroQol EQ-5D), Geriatric Depression Scale, Physical Activity Scale for
83 ms were measured at baseline by means of the Geriatric Depression Scale, Short-Form, with 6 to 7 symp
86 neuropsychological tests were administered: Geriatric Depression Scale, Trail Making A and B, Digit
88 for Epidemiologic Studies-Depression Scale, Geriatric Depression Scale-15, Hospital Anxiety and Depr
97 nts for 6-minute walk distance, QOL, and the geriatric depression score, but interactions did not ach
98 dex, education, leg symptoms, cigarette use, geriatric depression score, previous year's level of fun
99 ity-based computerized cognitive remediation-geriatric depression treatment (nCCR-GD) to target ED in
100 s recent progress in the characterization of geriatric depression using a variety of methodologies.
101 hanges in the neural systems predisposing to geriatric depression via the hypothalamic-pituitary-adre